Mayne forced to re-recall
Wednesday, 09 July, 2003
Complementary medicine giant Mayne Health has been caught out in the warehouse department, with some 650 bottles of TGA-banned and recalled products being accidentally delivered to retailers across Australia.
Mayne was alerted to the accidental deliveries by retailers and pharmacists in several states who notified they had been supplied with products recalled by the TGA following April’s suspension of sub-contractor Pan Pharmaceutical’s manufacturing licence.
“In the context of the whole recall, which was about 2 million items, this is a minute number of products,” argued Mayne spokeman Rob Tassie. “There were about 20 types of products across a variety of product lines that were missed in the original audit, and which were sent out from the warehouse,” he added.
Tassie said the products were accidentally sent out to customers as a result of “human error” in the initial audit, but that a second audit had just been completed to rectify the problem.
“It’s not to say we are disappointed, and in fact quite a few of the 650 bottles were not directly affected by the recall. Luckily there was only a limited number of retailers, at most a few hundred, that were affected.
“But we can’t always tell exactly which batch goes where,” he noted. “There were only 10 bottles sent to WA, for example,” he added.
The TGA says newspaper advertisements will run in New South Wales, Western Australia and South Australia tomorrow to try to recover the goods in question.
Stem cell experiments conducted in space
Scientists are one step closer to manufacturing stem cells in space — which could speed up...
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...